Combined hepatitis A and B vaccine: providing a bright future for preventing hepatitis.

作者信息

Hewlett Alex T

机构信息

University of Texas Medical Branch, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Galveston, TX 77555 - 0764, USA.

出版信息

Expert Opin Biol Ther. 2009 Sep;9(9):1235-40. doi: 10.1517/14712590903160639.

DOI:10.1517/14712590903160639

PMID:19601727

Abstract

The first combined hepatitis A and B vaccine has been available in the United States since 2001. The vaccine provides protection against viral hepatitis with rapid seroprotection and lasting immunogenicity. This review outlines the product's components, clinical efficacy and opportunities for use in special circumstances. The vaccine has a good safety profile and has good tolerability. The combined hepatitis A and B vaccine is a well studied vaccine that provides rapid seroconversion with a good safety profile.

摘要